Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Renata Kučerová Ph.D"'
Autor:
Michala Fiuraskova, Renata Kučerová Ph.D, Martina Bienová Ph.D, Svetlana Brychtova, Zdenek Kolar
Publikováno v:
Archives of Dermatological Research. 297:143-146
During the hair growth cycle, the hair follicle appears to recapitulate part of its embryogenesis where both beta-catenin and p63 participate. The aim of the present study was to investigate the hypothesis that beta-catenin and p63 protein may be inv
Autor:
Jason W. Brown, Allen L. Seligson, Renata Kučerová Ph.D, Martina Bienová Ph.D, Milos Sovak, Marian Hajduch, Ron Terry, Brian Campion
Publikováno v:
Drug Development Research. 59:292-306
Nonsteroidal antiandrogens (AA) cannot be topically used for androgenetic alopecia (AGA) because of systemic resorption. A new class of androgen receptor (AR) suppressors designed for safe topical treatment of AGA was synthesized from (3-amino-2-hydr
Autor:
Zdenek Kolar, Svetlana Brychtova, Renata Kučerová Ph.D, Martina Bienová Ph.D, Eva Sedlakova, Veronika Krejci, Michala Bezdekova, Alice Hlobilkova, Jana Steigerova, Tomas Brychta
Publikováno v:
Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia. 151(2)
Background Trichofolliculomas and trichoepitheliomas are benign skin neoplasms originating from hair follicle cells. They result from defects in the signaling pathways that regulate hair follicle morphogenesis and regeneration. Thus they seem to be a
Publikováno v:
Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia. 147(1)
Human hair morphogenesis is a dynamic process caused by the remodelling of the skin. Hair growth is cyclic in mammals consisting of three distinct stages: an active stage (anagen), a regressive stage (catagen), and a resting stage (telogen). One diso
Autor:
Marie Bienova, Milos Sovak, Allen L. Seligson, Renata Kučerová Ph.D, Marian Hajduch, Milan Bucek
Publikováno v:
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]. 28(8)
background. Fluridil, a novel topical antiandrogen, suppresses the human androgen receptor. While highly hydrophobic and hydrolytically degradable, it is systemically nonresorbable. In animals, fluridil demonstrated high local and general tolerance.